Article
AKT1 (E17K) mutation in pancreatic cancer.
Technology in cancer research & treatment - 1 Oct 2008
Mohamedali Azim, Lea Nicholas C, Feakins Roger M, Raj Kavita, Mufti Ghulam J, Kocher Hemant M
Abstract excerpt
The prevalence of a novel somatic mutation (E17K) in the pleckstrin homology domain of AKT1 was investigated in pancreatic cancer using a quantitative pyrosequencing assay. This mutation was un-detectable in pancreatic cancer tissue samples (n=65) and pancreatic cell line (n=10) DNA suggesting that pancreatic cancer progression is mainly dependent on the K-Ras mutation.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
